Anetoderma in a systemic lupus erythematosus patient with anti-PCNA and antiphospholipid antibodies

被引：13
|
作者：
Alvarez-Cuesta, CCA
Raya-Aguado, C
Fernández-Rippe, ML
Sánchez, TS
Pérez-Oliva, N
机构：
[1] Univ Oviedo, Hosp Cent Asturias, Dept Dermatol, E-33080 Oviedo, Spain
[2] Univ Oviedo, Hosp Cent Asturias, Dept Internal Med, E-33080 Oviedo, Spain
[3] Univ Oviedo, Hosp Cent Asturias, Dept Pathol, E-33080 Oviedo, Spain
来源：
DERMATOLOGY | 2001年 / 203卷 / 04期
关键词：
anetoderma; lupus; antiphospholipid antibody; anti-proliferating-cell-nuclear-antigen antibody;
D O I：
10.1159/000051789
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Anetoderma is a rare elastolytic disorder included within the group of cutaneous atrophies. Its pathogenesis is not yet clearly established, but immunological mechanisms could play an important role in dermal elastolysis. It has been associated with different autoantibodies and autoimmune disorders. We present a case of anetoderma in a systemic lupus erythematosus patient with anti-proliferating-cell-nuclear-antigen and antiphospholipid antibodies, highlighting the peculiarities of such an association. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码：348 / 350
页数：3
相关论文
共 50 条
  • [21] Anti-CD40 antibodies in antiphospholipid syndrome and systemic lupus erythematosus
    Vlachoyiannopoulos, PG
    Mavragani, CP
    Bourazopoulou, E
    Balitsari, AV
    Routsias, JG
    THROMBOSIS AND HAEMOSTASIS, 2004, 92 (06) : 1303 - 1311
  • [22] COVID-19 Coagulopathy in a Patient With Systemic Lupus Erythematosus and Antiphospholipid Antibodies
    Freeman-Beman, Latoya
    Ratner, Sabina
    Kabani, Naureen
    Neculiseanu, Elvira
    Ginzler, Ellen
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (02) : E60 - E61
  • [23] UNCOMPLICATED PREGNANCY AND BIRTH OF A HEALTHY CHILD BY A WOMAN WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND ANTI-U1RNP, ANTI-PCNA/CYCLIN, ANTI-DSDNA AND ANTIPHOSPHOLIPID AUTOANTIBODIES
    AUERGRUMBACH, P
    RAMSCHAK, H
    KAINER, F
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1994, 19 (05) : 401 - 403
  • [24] Antiphospholipid antibodies and cognitive dysfunction in systemic lupus erythematosus
    Barraclough, Michelle
    McKie, Shane
    Parker, Ben
    Elliott, Rebecca
    Bruce, Ian N.
    LUPUS, 2019, 28 : 22 - 22
  • [25] ANTIPHOSPHOLIPID ANTIBODIES IN PEDIATRIC SYSTEMIC LUPUS-ERYTHEMATOSUS
    SEAMAN, DE
    LONDINO, AV
    MANZI, S
    MEDSGER, TA
    ARTHRITIS AND RHEUMATISM, 1993, 36 (05): : R15 - R15
  • [26] Guidelines for looking at the antiphospholipid antibodies in systemic lupus erythematosus
    Stratta, P
    Canavese, C
    Ferrero, S
    Grill, A
    Piccoli, G
    NEPHRON, 1997, 76 (04): : 400 - 405
  • [27] Systemic lupus erythematosus, hypercoagulable states, and antiphospholipid antibodies
    Roubey, RAS
    ARTHRITIS CARE AND RESEARCH, 1999, 12 (03): : 155 - 156
  • [28] CIGARETTE SMOKING AND ANTIPHOSPHOLIPID ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Gustafsson, J.
    Gunnarsson, I.
    Pettersson, S.
    Zickert, A.
    Vikerfors, A.
    Hellbacher, E.
    Moller, S.
    Elvin, K.
    Simard, J. F.
    Svenungsson, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 217 - 217
  • [29] Antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus
    Formiga, F
    Moga, I
    Canet, R
    Pac, M
    Mitjavila, F
    Pujol, R
    REVISTA CLINICA ESPANOLA, 1996, 196 (11): : 734 - 736
  • [30] ANTIPHOSPHOLIPID ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    HAZELTINE, M
    RAUCH, J
    DANOFF, D
    ESDAILE, J
    TANNENBAUM, H
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (03): : A160 - A160
12345